HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma.

AbstractBACKGROUND:
Autologous stem cell transplantation (ASCT) generally provides good results in Hodgkin's lymphoma (HL). We studied a high-dose chemotherapy regimen based on thiotepa, etoposide and carboplatin (TECA).
METHODS:
Fifty-eight patients with advanced HL were treated with thiotepa, etoposide and carboplatin for transplant induction.
RESULTS:
The overall response rate was 79·3% (39 CR: 67·2%; and 7 PR: 12·1%); 12 patients (20·1%) were non-responders. The 5-year overall survival rate was 77·6%; five initially responder patients relapsed within the first 5 years of follow-up and underwent salvage therapy.
CONCLUSION:
The TECA conditioning regimen for ASCT in HL results in a good anti-HL effect, positive response to treatment and high 5-year overall survival rate. It was also well tolerated and did not induce excessive toxicity, suggesting that TECA may be a very useful conditioning regimen for HL.
AuthorsMauro Di Ianni, Stelvio Ballanti, Giuseppe Iodice, Antonia Reale, Franca Falzetti, Olivia Minelli, Gabriella Serio, Massimo F Martelli, Franco Dammacco, Angelo Vacca, Roberto Ria
JournalHematology (Amsterdam, Netherlands) (Hematology) Vol. 17 Issue 1 Pg. 23-7 (Jan 2012) ISSN: 1607-8454 [Electronic] England
PMID22549444 (Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bleomycin
  • Vinblastine
  • Etoposide
  • Dacarbazine
  • Doxorubicin
  • Thiotepa
  • Carboplatin
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Bleomycin (administration & dosage)
  • Carboplatin (administration & dosage)
  • Dacarbazine (administration & dosage)
  • Disease-Free Survival
  • Doxorubicin (administration & dosage)
  • Etoposide (administration & dosage)
  • Hematopoietic Stem Cell Transplantation (methods)
  • Hodgkin Disease (drug therapy, surgery)
  • Humans
  • Kaplan-Meier Estimate
  • Middle Aged
  • Survival Rate
  • Thiotepa (administration & dosage)
  • Transplantation Conditioning (methods)
  • Transplantation, Autologous
  • Treatment Outcome
  • Vinblastine (administration & dosage)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: